Blyss Cloud – Why We Love The Strainprint Marijuana App
Recently, the Strainprint App was featured on Blyss Cloud. Read all about why they love the Strainprint App!
Strainprint Launches Custom App Version For Canna Farms
Strainprint™ — the leader in cannabis data collection and strain efficacy reporting — is pleased to announce the release of the Canna Farms OEM version of the Strainprint mobile App. The newest custom-branded version of the Strainprint App is available exclusively for Canna Farms customers through a unique activation code.
Stephanie Karasick On The 420 Radio Show
On Friday, November 10th Strainprint Founder, Stephanie Karasick appeared on the 420 Radio Show. Get more information, or to listen to the full interview here!
Investing News Network: Changing the Limitations of Cannabis Research
On August 30th, 2017 Strainprint was featured on the Investing News Network. Our President, Dave Berg spoke to the Investing News Network about Strainprint and how we’re working to change the limitations of Medical Cannabis Research.
Strainprint Opens its Ambassador Program With IMPACT Network
Strainprint™, the leader in cannabis data collection and strain efficacy reporting, is pleased to announce the launch of its Ambassador Research Program. The Strainprint Ambassador program is available to qualified researchers that use Strainprint’s revolutionary data gathering and analytics tools to conduct observational cannabis studies in relation to specific medical conditions.
Strainprint Expands Coverage With the Addition of Harvest Medicine
Strainprint™ Technologies Ltd. Expands Nationwide Coverage With the Addition of Harvest Medicine to The Strainprint Community PRESS RELEASE Toronto, August 2, 2017 – Strainprint, the leader in cannabis data collection and strain efficacy reporting [analytics], is pleased to welcome Harvest Medicine cannabis clinic to its growing list of data customers. Based in Calgary, Alberta, Harvest […]
Strainprint Announces The Formation of A Board of Medical Advisors
Strainprint™, the leader in cannabis data collection, is pleased to welcome Dr. Lyle Oberg, Dr. Sana-Ara Ahmed, and Dr. HJ Raza to its Board of Medical Advisors. Strainprint™ works closely with its medical advisors to support patients, enhance research and advance the scientific understanding of cannabinoid therapy.
Strainprint Announces Partnership With Emblem Cannabis Corp.
Strainprint Technologies Ltd. (“Strainprint”) — the leader in cannabis patient and strain efficacy data — is excited to announce the launch of the first ever co-branded version of its revolutionary mobile outcomes-tracking App with Emblem Cannabis Corp.
Strainprint Closes Private Investment Round
Strainprint, the leader in cannabis patient and strain efficacy data, is pleased to announce that it has recently closed a private investment round. The Company plans to use proceeds to aggressively build brand and presence in legal North American markets through education and awareness campaigns.